|
| | 2,6-Dimethylpiperidine Basic information |
| Product Name: | 2,6-Dimethylpiperidine | | Synonyms: | 2,6-DIMETHYLPIPERIDINE;26LPT;2,6-LUPETIDINE;2,6-dimethyl-piperidin;AKOS BBS-00000942;TIMTEC-BB SBB004313;Lupetidin;Lupetidine | | CAS: | 504-03-0 | | MF: | C7H15N | | MW: | 113.2 | | EINECS: | 207-981-6 | | Product Categories: | | | Mol File: | 504-03-0.mol |  |
| | 2,6-Dimethylpiperidine Chemical Properties |
| Melting point | <-20°C | | Boiling point | 127-128 °C768 mm Hg(lit.) | | density | 0.84 g/mL at 25 °C(lit.) | | refractive index | n20/D 1.4394(lit.) | | Fp | 53 °F | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | solubility | Soluble in DMSO | | form | liquid | | pka | 10.82±0.10(Predicted) | | color | Clear, colourless | | Water Solubility | MISCIBLE | | Sensitive | Air Sensitive | | BRN | 79827 | | CAS DataBase Reference | 504-03-0(CAS DataBase Reference) | | NIST Chemistry Reference | Nanofin(504-03-0) | | EPA Substance Registry System | Piperidine, 2,6-dimethyl- (504-03-0) |
| | 2,6-Dimethylpiperidine Usage And Synthesis |
| Chemical Properties | clear colorless to slightly yellow liquid | | Uses | 2,6-Dimethylpiperidine is used for n silico study for drug repositioning and novel candidate drugs in anti-tumor necrosis factor refractory Crohn's disease in patients. |
| | 2,6-Dimethylpiperidine Preparation Products And Raw materials |
|